91 related articles for article (PubMed ID: 20446597)
1. [Therapeutic angiogenesis for diabetes mellitus related ischemic disease].
Taniyama Y; Sanada F; Morishita R
Nihon Rinsho; 2010 May; 68(5):949-52. PubMed ID: 20446597
[TBL] [Abstract][Full Text] [Related]
2. [The latest review of therapeutic angiogenesis using angiogenic growth factors to peripheral arterial diseases].
Aoki M; Ogihara T; Morishita R
Nihon Rinsho; 2002 Sep; 60(9):1845-55. PubMed ID: 12233086
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor as potential cardiovascular therapy.
Nakagami H; Kaneda Y; Ogihara T; Morishita R
Expert Rev Cardiovasc Ther; 2005 May; 3(3):513-9. PubMed ID: 15889978
[TBL] [Abstract][Full Text] [Related]
5. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
6. [Overview on diagnosis, treatment and therapeutic angiogenesis for arteriosclerosis obliterans].
Ozaki K; Morishita R; Ogihara T
Nihon Rinsho; 2006 Nov; 64(11):2045-51. PubMed ID: 17087295
[TBL] [Abstract][Full Text] [Related]
7. In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade.
Hashiya N; Jo N; Aoki M; Matsumoto K; Nakamura T; Sato Y; Ogata N; Ogihara T; Kaneda Y; Morishita R
Circulation; 2004 Jun; 109(24):3035-41. PubMed ID: 15173033
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence.
Sanada F; Taniyama Y; Azuma J; Iekushi K; Dosaka N; Yokoi T; Koibuchi N; Kusunoki H; Aizawa Y; Morishita R
Hypertension; 2009 Jan; 53(1):77-82. PubMed ID: 19047582
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic angiogenesis for ischemic diseases].
Aoki M; Morishita R
Nihon Rinsho; 2006 Apr; 64(4):762-8. PubMed ID: 16613196
[TBL] [Abstract][Full Text] [Related]
10. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
[TBL] [Abstract][Full Text] [Related]
11. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
[TBL] [Abstract][Full Text] [Related]
12. Endothelial progenitor cells in clinical settings.
Sanada S; Taniyama Y; Azuma J; Yuka II; Iwabayashi M; Rakugi H; Morishita R
J Stem Cells; 2014; 9(2):117-25. PubMed ID: 25158160
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.
Gounis MJ; Spiga MG; Graham RM; Wilson A; Haliko S; Lieber BB; Wakhloo AK; Webster KA
Gene Ther; 2005 May; 12(9):762-71. PubMed ID: 15772688
[TBL] [Abstract][Full Text] [Related]
14. Regenerative therapy in peripheral artery disease.
Germani A; Di Campli C; Pompilio G; Biglioli P; Capogrossi MC
Cardiovasc Ther; 2009; 27(4):289-304. PubMed ID: 19903190
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
Deuse T; Peter C; Fedak PW; Doyle T; Reichenspurner H; Zimmermann WH; Eschenhagen T; Stein W; Wu JC; Robbins RC; Schrepfer S
Circulation; 2009 Sep; 120(11 Suppl):S247-54. PubMed ID: 19752375
[TBL] [Abstract][Full Text] [Related]
16. Novel therapeutic strategy to treat brain ischemia: overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model.
Shimamura M; Sato N; Oshima K; Aoki M; Kurinami H; Waguri S; Uchiyama Y; Ogihara T; Kaneda Y; Morishita R
Circulation; 2004 Jan; 109(3):424-31. PubMed ID: 14707023
[TBL] [Abstract][Full Text] [Related]
17. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
[TBL] [Abstract][Full Text] [Related]
18. [Research advance of gene therapy for peripheral arterial disease using hepatocyte growth factor].
Zhang Q; Li Y; Wu Z
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Nov; 20(11):1147-50. PubMed ID: 17191586
[TBL] [Abstract][Full Text] [Related]
19. Cooperative signaling for angiogenesis and neovascularization by VEGF and HGF following islet transplantation.
Golocheikine A; Tiriveedhi V; Angaswamy N; Benshoff N; Sabarinathan R; Mohanakumar T
Transplantation; 2010 Oct; 90(7):725-31. PubMed ID: 20714284
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets.
Aoki M; Morishita R; Taniyama Y; Kida I; Moriguchi A; Matsumoto K; Nakamura T; Kaneda Y; Higaki J; Ogihara T
Gene Ther; 2000 Mar; 7(5):417-27. PubMed ID: 10694824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
